Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 74.30 +0.96%   SPY: 166.94 +0.97%
Quote Spy TSRX NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.


Trius Therapeutics (TSRX)

@ May-17
Click the portfolio to add TSRX:
Close [X]
+ Add TSRX to Portfolio
  
  Last Trade: $7.98 +0.10 (1.27%)
  Volume: 731,868 91% of avg daily volume
       
  Avg Volume: 806,899
3-Month Chart (Larger chart w/volume)
Close [X]
1m  3m  6m  1y  2y
  Day's Range: 7.91 - 8.15
  Open: 7.93
  Previous Close: 7.88
  52-wk Range: 4.41 - 8.50
  Market Cap: 381.9M
  P/E: -5.3
  Div Yield: $0.00 (0.00%)
Indexes
2010 IPOs (-0.2%)
Biotechnology Stocks (+0.7%)
Spy TSRX

? Pro holders
? Member holders
? Items submitted
Additional TSRX resources



Customize Links
To see which Pros and tickerspy members own TSRX Sign up now
Latest TSRX Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Trius Announces Notice of Allowance of U.S. Patent Application Related to Tedizolid Phosphate Combination With Daptomycin
TSRX  
Linked by GlobeNewswire - May 13, 08:13AM from (globenewswire.com)
SAN DIEGO, May 13, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused on  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics to Present Experimental Antibiotic Study Results at ECCMID Meeting
TSRX  
Linked by GlobeNewswire - April 23, 08:13AM from (globenewswire.com)
SAN DIEGO, April 23, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that the results of  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Appoints Seth Fischer to Its Board of Directors
TSRX  
Linked by GlobeNewswire - April 03, 04:13PM from (globenewswire.com)
SAN DIEGO, April 3, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today the appointment of Seth  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius to Present at Future Leaders Conference
TSRX  
Linked by GlobeNewswire - April 02, 04:13PM from (globenewswire.com)
SAN DIEGO, April 2, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) announced today that Jeffrey Stein, Ph.D.,  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics Reports 2012 Fourth Quarter and Full Year 2012 Financial Results
TSRX  
Linked by GlobeNewswire - March 12, 04:13PM from (globenewswire.com)
SAN DIEGO, March 12, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Announces Publication of Tedizolid ESTABLISH 1 Trial in JAMA
TSRX  
Linked by GlobeNewswire - February 12, 04:43PM from (globenewswire.com)
SAN DIEGO, Feb. 12, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares for Common Stock Offering
TSRX  
Linked by GlobeNewswire - January 23, 08:13AM from (globenewswire.com)
SAN DIEGO, Jan. 23, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced that the underwriters  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics, Inc. Prices Public Offering of Common Stock
TSRX  
Linked by GlobeNewswire - January 18, 08:13AM from (globenewswire.com)
SAN DIEGO, Jan. 18, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced the pricing of an underwritten  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
TSRX  
Linked by GlobeNewswire - January 17, 04:43PM from (globenewswire.com)
SAN DIEGO, Jan. 17, 2013 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced that it intends to offer  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Trius Therapeutics Completes Enrollment in Second Phase 3 Trial of Tedizolid for Skin and Skin Structure Infections
TSRX  
Linked by GlobeNewswire - December 10, 08:13AM from (globenewswire.com)
SAN DIEGO, Dec. 10, 2012 (GLOBE NEWSWIRE) -- Trius Therapeutics, Inc. (Nasdaq:TSRX), a biopharmaceutical company focused  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7



Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource